Crosscheck

Your medical. Crosschecked.

Bones

Romosozumab

Sclerostin inhibitor, monoclonal antibody
Other names: Evenity

FAA guidance

Acceptable with conditions.

Wait

2 weeks

initial observation

Different waits apply in other cases.

Examiner

The examiner can issue when the document's criteria are met

FAA label

ACCEPTABLE

Source: FAA, Osteoporosis Medications. FAA date 26 August 2026. Checked by Crosscheck 14 October 2026

The FAA lists romosozumab as acceptable osteoporosis medication when the certification criteria are met, with a two-week initial observation and four hours after each dose; if it is used for cancer-related conditions, additional observation periods and/or requirements may apply.

Track your medications
More detail: romosozumabThe rest of the wait, and the FAA rules behind this answerOpen

Wait

  • 4 hours after each dose
  • 14 days after starting: ground observation
  • 4 hours after each dose: ground observation
Show the FAA's words: romosozumabThe official FAA wording: one passage, each with its document and dateOpen
FAA, Osteoporosis Medications · FAA date 26 August 2026
ACCEPTABLE Osteoporosis Medications (when certification criteria are met).
Sclerostin Inhibitor; Monoclonal Antibody: romosozumab (Evenity), 2 weeks, 4 hours
Above guidance is for osteoporosis treatment ONLY. If used for cancer-related conditions, additional observation periods and/or requirements may apply.
Sources and dates: romosozumabOne FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.